Sirio Pharma introduces plant-based nutraceutical CDMO services

The China-based nutraceutical contract development, innovation and manufacturing organisation has debuted plant-based solutions across all dosage form platforms

Photo as seen on company website

Ahead of SupplySide West, Sirio Pharma [Booth 4958], the nutraceutical contract development, innovation and manufacturing organisation (CDIMO), has unveiled a full spectrum of one-stop-services for all plant-based products and has announced plans for 2020.

The company is using the event to actively promote its integrated solutions in plant-based nutraceuticals. Sirio offers plant-based solutions across all dosage form platforms. The Sirio Group is able to rapidly develop customer products across the entire spectrum of delivery formats - including gummies, softgels, and tablets. The company also offers organic softgels at Ayanda's European site - a Sirio Group company - with plans underway to get organic certification across all sites.

Doug Brown, Director Americas at Sirio Pharma, said: "What you see in the wider market are some contract providers across formats such as tablets and softgels working on plant-based solutions here and there. Sirio is leading the market delivering plant-based solutions across all delivery formats - gummies, softgels, tablets, powders and liquids. Sirio has a wide range of capabilities and, just as crucially, experience formulating these compounds for customers globally."

Sirio anticipates 2020 will be the year that companies look to ensure they have plant-based options across all product classes

The company anticipates that many customers, particularly those in the US and Europe, are now looking at ways to move their entire product portfolios across to plant-based solutions and using one contract provider presents a good number of advantages.

Brown added: "It is strategically important that customers transitioning entire lines to plant-based formats know that there is a trusted, experienced partner in Sirio that can deliver end-to-end development, formulation and manufacturing services for them delivered anywhere in the world on time and in full."

The company's plant-based one-stop-services focus at SupplySide West marks the start of an extended push to global customers, with Sirio also introducing the platform to European customers at CPhI Worldwide in November.

Sirio anticipates that while the plant-based movement has been building for a number of years, 2020 will be the year that companies look to ensure they have plant-based options across all product classes.

Significantly, this will have implications for the capabilities needed from CDMO partners. Sirio entered this market early on with its patented technologies for softgels and pectin-based gummies. With many new customised products potentially needed, the company predicts an extremely large demand for full-service plant-based capabilities.

Companies